Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 6,000
- Avg volume
- 2,626
- Day's range
- $0.02 – $0.06
- Shares out
- —
- Stochastic %K
- 0%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system through formulations of GLP-1 combination therapies for obesity and metabolic disorders. The company is based in Vancouver, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- (888) 436 7772
- Website
- https://www.lirlifesciences.com
- Address
- 1505 West 2nd Avenue, Suite 506, Vancouver, Canada
Latest news
No headlines yet.
